Kexing Biopharm Co., Ltd. (SHA:688136)

Kexing Biopharm Revenue

Kexing Biopharm had revenue of 280.53M CNY in the quarter ending March 31, 2026, a decrease of -20.66%. This brings the company's revenue in the last twelve months to 1.46B, up 4.37% year-over-year. In the year 2025, Kexing Biopharm had annual revenue of 1.53B with 9.03% growth.

• Revenue (ttm): 1.46B
• Revenue Growth: +4.37%
• P/S Ratio: 3.53
• Revenue / Employee: 1.54M
• Employees: 971
• Market Cap: 5.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.53B	127.10M	9.03%
Dec 31, 2024	1.41B	147.89M	11.75%
Dec 31, 2023	1.26B	-56.84M	-4.32%
Dec 31, 2022	1.32B	30.70M	2.39%
Dec 31, 2021	1.29B	64.88M	5.32%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error